We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 16 for:    ketamine bipolar disorder
Previous Study | Return to List | Next Study

Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder (IKBP)

This study has been terminated.
(Administrative issues)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01504659
First Posted: January 5, 2012
Last Update Posted: March 16, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Juvenile Bipolar Research Foundation
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2016
  Primary Completion Date: November 2016 (Final data collection date for primary outcome measure)